This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rose 5.8% to $6.79 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.6% to 17,754.09 and the Dow Jones Industrial Average rising 1.7% to 41,488.19.
Corbus Pharmaceuticals Holdings Inc. closed 89.0% short of its 52-week high of $61.90, which the company achieved on July 31st.
The stock outperformed some of its competitors, as Vanda Pharmaceuticals Inc. rose 1.2% to $4.98, Fortress Biotech Inc. rose 3.1% to $1.67, and Viking Therapeutics Inc. rose 3.90% to $30.89.
Trading volume totaled 135,971, compared to the 50-day average of 244,556.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 14, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。